ClinSegNet: Towards Reliable and Enhanced Histopathology Screening

ClinSegNet:迈向可靠且更高效的组织病理学筛查

阅读:2

Abstract

In histopathological image segmentation, existing methods often show low sensitivity to small lesions and indistinct boundaries, leading to missed detections. Since, in clinical diagnosis, the consequences of missed detection are more serious than false alarms, this study proposes ClinSegNet, a recall-oriented and human-centred framework for reliable histopathology screening. ClinSegNet employs a composite optimisation strategy, termed HistoLoss, which balances stability and boundary refinement while prioritising recall. An uncertainty-driven refinement mechanism is further introduced to target high-uncertainty cases with limited fine-tuning cost. In addition, a clinical data processing pipeline was developed, where pixel-level annotations were automatically derived from IHC-to-H&E mapping and combined with public datasets, enabling effective training under limited clinical data conditions. Experiments on the NuInsSeg and NuInsSeg-UHS datasets showed that ClinSegNet achieved recall scores of 0.8803 and 0.8917, further improved to 0.8983 and 0.9053 with HITL refinement, while maintaining competitive Dice and IoU. Comparative and ablation studies confirmed the complementary design of the framework and its advantage in capturing small or complex lesions. In conclusion, ClinSegNet provides a clinically oriented, recall-prioritised framework that enhances lesion coverage, reduces the risk of missed diagnosis, and offers both a methodological basis for future human-in-the-loop systems and a feasible pipeline for leveraging limited clinical data.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。